OBJECTIVE	To identify the optimal schedule for infusion of cytarabine ( ara-C ) given with cladribine ( 2-CdA ) to pediatric patients with acute myeloid leukemia ( AML ) , and to compare the effects of the two schedules on the pharmacokinetics of ara-C triphosphate ( ara-CTP ) in leukemic cells .\